Urinary incontinence (UI) is a major problem in health care and more than 400 million
people worldwide suffer from involuntary loss of urine. With an increase in the aging …

Stress urinary incontinence (SUI) adversely affects the quality of life of patients, while the
currently available surgical and non-surgical therapies are not effective in all patients …

Despite intensive clinical research on the use of mesenchymal stromal cells (MSCs), further
basic research in this field is still required. Herein, we compared human bone marrow MSCs …

Background Cell therapy constitutes an attractive alternative to treat stress urinary
incontinence. Although promising results have been demonstrated in this field, the …

Aims In a recent preclinical study, we noticed that injection of cells in the urethral sphincter
by needle through a cystoscope under visual control frequently yielded in misplacement or …

Current regimen to treat patients suffering from stress urinary incontinence often seems not
to yield satisfactory improvement or may come with severe side effects. To overcome these …

Objectives To investigate the therapy of stress urinary incontinence in a preclinical setting
cells were injected into the urethrae of minipigs; however, cells injected by William's needle …

Mesenchymal stem cells (MSCs), also referred to as multipotent stromal cells or
mesenchymal stromal cells, are present in multiple tissues and capable of differentiating into …

Stem cells are capable of self-renewal, differentiation, and the promotion of the release of
chemokines and progenitor cells essential for tissue regeneration. Stem cells have the …

High-rate complications and recurrences in reconstructive surgery using in situ synthetic/
polypropylene meshes have driven to a new era of mesenchymal stem cells (MSCs) and/or …